Pacira BioSciences, Inc. (Nasdaq: PCRX) announced the issuance of inducement awards to seven new employees on July 2, 2025, under its Amended and Restated 2014 Inducement Plan. Approved by the People & Compensation Committee of the Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4), these awards were granted without stockholder approval. The package includes stock options for one employee to purchase 3,500 shares at an exercise price of $23.21 per share, with a 10-year term and a four-year vesting schedule. Additionally, seven employees received restricted stock units for a total of 12,300 shares, vesting annually over four years starting July 1, 2026. The vesting of these equity awards is contingent upon the employees' continued employment with Pacira.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.